⚠ Research and educational use only — not for human consumption. Nothing for sale, no dosing advice. PeptideCompare is non-profit and independent.
Compare free →
Suppliers 🛡 Quality & badges 📖 Encyclopedia 📰 Articles 🧪 Calculator
LONGEVITY TOPICS
⚡ NAD+ Precursors 🔑 Sirtuin Activators 🧹 Senolytics ♻️ Autophagy 🔋 Mitochondrial 🌡️ Hormesis
About FAQ Contact Policy
MONOGRAPH No. 117
TYPE
GnRH decapeptide
MW
1182.3 g/mol
CAS
33515-09-2
EU STATUS
Rx-only medicine + Research grade
WADA
Prohibited S2 (in males)
MIN PURITY
≥98% HPLC
⚡ Growth Hormone Axis

Gonadorelin — EU research guide.

Gonadorelin is the native gonadotropin-releasing hormone (GnRH) — a decapeptide used clinically for fertility testing and, in the research/biohacking community, to help maintain testicular function during testosterone therapy.

Last reviewed:

What is Gonadorelin?

Gonadorelin stimulates the pituitary to release LH and FSH, which in turn drive natural testosterone production and spermatogenesis. Pulsatile dosing mimics the body's own GnRH rhythm; continuous dosing instead desensitises the pituitary — the opposite effect, used deliberately by long-acting GnRH agonist drugs.

Clinical and research use

Clinically, gonadorelin is used for diagnostic pituitary-function testing and, off-label, alongside exogenous testosterone to help preserve fertility and testicular size — the same rationale behind hCG use, though gonadorelin acts one step higher in the hypothalamic-pituitary-gonadal axis.

EU legal status

Approved as a prescription medicine in several EU countries for diagnostic use; also available as a research-grade peptide. WADA prohibits GnRH and its agonists for male athletes (S2), since they can raise endogenous testosterone.

Prescription-only medicine in most EU countries; WADA-prohibited for male athletes. Short half-life requires frequent or pulsatile dosing to be effective.
✓ For the related HPG-axis compound used in similar protocols, PeptideCompare tracks hCG from EU research vendors with COA documentation.

Molecular information

Molecular formula
C55H75N17O13
Molecular weight
1182.3 g/mol
CAS number
33515-09-2

Pharmacokinetics

Route
Intravenous
Half-life (t½)
≈2–8 min
Source: Handelsman & Swerdloff, Endocr Rev 1986; FDA NDA 017866
Research context only — not dosing guidance.

HPG-axis compounds across EU suppliers

COA-verified EU vendors · Updated monthly

Frequently asked questions

What is Gonadorelin?

Gonadorelin is a GnRH decapeptide that stimulates the pituitary to release LH and FSH, which in turn drive natural testosterone production and spermatogenesis.

Why does the dosing pattern matter for Gonadorelin?

Pulsatile dosing mimics the body's own GnRH rhythm, whereas continuous dosing desensitises the pituitary, the opposite effect, which is used deliberately by long-acting GnRH agonist drugs.

How is Gonadorelin used clinically?

It is used for diagnostic pituitary-function testing and, off-label, alongside exogenous testosterone to help preserve fertility and testicular size.

How does Gonadorelin differ from HCG?

Both aim to preserve fertility and testicular size, but gonadorelin acts one step higher in the hypothalamic-pituitary-gonadal axis by stimulating the pituitary rather than the testes directly.

Is Gonadorelin legal in the EU?

It is approved as a prescription medicine in several EU countries for diagnostic use and is also available as a research-grade peptide.

Is Gonadorelin banned in sport?

Yes. WADA prohibits GnRH and its analogs in males (S2).

Related guides

PeptideCompare AssistantOnline · replies instantly
Hi! I help you quickly find the right page — about legality, COAs, badges or suppliers. No price advice, no dosing.
Try a question
What does COA Verified mean? Most tested supplier? Is this legal here?
Navigation assistant · no medical advice